Assessment of LV Myocardial Scar Before Atrial Fibrillation Ablation∗  by Kwong, Raymond Y. & Farzaneh-Far, Afshin
J A C C : C A R D I O V A S C U L A R I M A G I N G VO L . 8 , N O . 7 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 5 . 0 4 . 0 0 7EDITORIAL COMMENTAssessment of LV Myocardial Scar
Before Atrial Fibrillation Ablation*
Raymond Y. Kwong, MD, MPH,y Afshin Farzaneh-Far, MD, PHDzxC atheter ablation has become an establishedtherapeutic option in symptomatic patientswith atrial ﬁbrillation (1); however, long-
term procedural success has been disappointing
because of arrhythmia recurrence in up to 25% of
patients at 1 year and 40% at 5 years (1). The need
for repeat ablations remains a major problem. More-
over, the procedure is associated with a nontrivial
risk of serious complications. Thus, understanding
the factors that determine arrhythmia recurrence
is critical to clinical decision making. Common vari-
ables predictive of atrial ﬁbrillation recurrence after
ablation include the presence of nonparoxysmal
atrial ﬁbrillation, left ventricular systolic dysfunc-
tion, heart failure, structural/valvular heart disease,
left atrial enlargement, hypertension, and duration
of atrial ﬁbrillation (2). However, these associations
are generally weak and not universally observed.
Therefore, currently there is no accepted way to
individualize the risk of recurrence.
Cardiac magnetic resonance (CMR) can be used
to provide pre-procedural anatomic information,
particularly regarding the location of the pulmonary
veins. This typically involves gated post-contrast
acquisition of a 3-dimensional volume set that en-
compasses the left atrium and pulmonary veins, with
subsequent integration into the electroanatomic
mapping system used during the procedure. How-
ever, CMR is also capable of providing a wealth of
other information about the heart that may be infor-
mative in these patients. This includes assessment*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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presence of thrombus (3–6).
Late gadolinium enhancement (LGE) with CMR has
emerged as the gold standard technique for imaging
of myocardial scar and focal ﬁbrosis (7). The basic
principle is inversion-recovery imaging after a 5- to
10-min delay after intravenous administration of gad-
olinium contrast. With appropriate settings, normal
myocardium appears nulled or black, whereas regions
of scar or focal ﬁbrosis appear bright (enhanced).
The mechanism underlying LGE is likely based on
the inability of gadolinium chelates to cross intact
cell membranes. In regions of scar or focal ﬁbrosis,
the interstitial space is expanded, which leads to
increased gadolinium concentrations, shortened T1
relaxation times, and consequent signal enhancement.
The presence and extent of ventricular LGE have
been shown to be signiﬁcant adverse predictors of
events in numerous conditions, including ischemic
and nonischemic cardiomyopathies, diabetes melli-
tus, valvular heart disease, hypertrophic cardiomy-
opathy, myocarditis, amyloidosis, and sarcoidosis.
The presence of unrecognized myocardial infarction
by LGE is a strong predictor of death in symp-
tomatic and asymptomatic people, including in a
large population-based study of older people (8).
The mechanism for these adverse associations may
involve regions of LGE that act as a substrate for
ventricular arrhythmias. Recently, Neilan et al. (4)
showed the prognostic value of myocardial LGE in
predicting all-cause mortality in 664 patients without
known prior myocardial infarction who were referred
for atrial ﬁbrillation ablation and followed up for a
median of 42 months. They found regions of left
ventricular LGE in 13% of their patients. Both the
presence and extent of LGE were associated with
mortality. The mortality rate was 8.1% per patient-
year in those with LGE compared with 2.3% in
patients without LGE.
It is on this background that the question of the
impact of left ventricular LGE on atrial arrhythmia
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802recurrence arises. In this issue of iJACC, Suksaranjit
et al. (9) performed contrast-enhanced 3-dimensional
angiography, as well as ventricular and left atrial LGE
imaging, before atrial ﬁbrillation ablation in 778
patients. The primary endpoint was atrial arrhythmia
recurrence, assessed by 8-day Holter monitoring at 3,
6, and 12 months and yearly thereafter. In addition,
symptom-guided Holter monitoring and 12-lead
electrocardiograms were also used at the physicians’
discretion. Atrial arrhythmia recurrence was deﬁned
as any sustained atrial arrhythmia that lasted >30 s
without antiarrhythmic drugs. After a median follow-
up of 52 months, 40% of patients had atrial
arrhythmia recurrence. Left ventricular LGE was
detected in 6.5% of their patients. The recurrence rate
was 69% in patients with left ventricular LGE
compared with 38% in those without LGE. In their
ﬁnal multivariable model, only left ventricular and
left atrial LGE were independent predictors of atrial
arrhythmia recurrence.SEE PAGE 793What is the possible mechanism linking left
ventricular LGE with atrial arrhythmia recurrence?
The authors suggest that the presence of ventricular
ﬁbrosis alters the diastolic ﬁlling properties of the left
ventricle, resulting in a less compliant chamber and
consequent elevation of left ventricular end-diastolic
and left atrial pressures, which leads to atrial stretch
and remodeling. Left atrial volume was not presented
in the paper, but 2-dimensional left atrial “area”
was found to be signiﬁcantly larger in patients
with left ventricular LGE and associated with atrial
arrhythmia recurrence in unadjusted analysis. The
authors do not provide functional data regarding
left ventricular diastolic ﬁlling properties. However, a
recent study by Dodson et al. (5) shed some light on
this by assessing left atrial passive function with CMR
in 346 patients before atrial ﬁbrillation ablation.
Maximum left atrial volumes (VOLmax) and volumes
before atrial contraction (VOLbac) were measured.
Left atrial passive function was calculated as:
(VOLmax  VOLbac) / VOLmax  100. After adjustment
for age, sex, and known clinical characteristics asso-
ciated with atrial ﬁbrillation recurrence (hyperten-
sion, diabetes mellitus, VOLmax, nonparoxysmal
atrial ﬁbrillation, left ventricular ejection fraction,
history of prior ablation), left atrial passive function
remained a strong predictor of atrial ﬁbrillation
recurrence. Left atrial passive function occurs in early
diastole and represents the conduit phase of left atrial
function as blood is transferred from the pulmonary
veins into the left ventricle (10). In patients with
impaired left ventricular relaxation, ﬁlling pressuresincrease and left atrial passive function declines.
However, assessment of left atrial passive function
requires the presence of sinus rhythm, and it was
not clear what proportion of patients in the study
by Suksaranjit et al. (9) were in atrial ﬁbrillation at
the time of imaging.
Interestingly, Suksaranjit et al. (9) state that they
used a single-shot, free-breathing technique for
left ventricular LGE image acquisition and interpre-
tation. This results in decreased spatial resolution
and greater partial volume effects and may have
impacted their ability to visualize small areas of left
ventricular LGE (11). This may explain in part the
lower prevalence of left ventricular LGE in this
study compared with similar populations examined
by Dodson et al. (5) and Neilan et al. (4).
The authors also measured left atrial LGE, and their
group has published several papers using this tech-
nique, including a recent multicenter study sug-
gesting an association with arrhythmia recurrence
(6). It is notable that both left ventricular and left
atrial LGE were independently associated with atrial
arrhythmia recurrence in the current study, which
indicates that atrial remodeling and LGE are not
purely secondary to ventricular LGE. However, at
present, LGE imaging of the thin-walled atrium in
patients with frequently irregular heartbeats is
challenging to perform. In contrast, ventricular LGE
imaging is easy to do and universally available. Data
from the current study and the work of Neilan et al.
suggest that this provides additional useful prognostic
information and should be considered in patients
undergoing CMR before atrial ﬁbrillation ablation.
Another interesting question raised by this work
relates to the origin of the underlying ventricular
LGE. The authors analyzed the pattern of LGE and
found that almost one-half of the cases were sub-
endocardial or transmural in location and therefore
likely caused by underlying myocardial infarction.
This presumably relates to either underlying coronary
artery disease or embolic phenomenon. It would
therefore be of interest to know what proportion of
patients in the current study had a known history of
coronary artery disease (patients with known prior
myocardial infarction were excluded). The cause of
LGE in the remainder of cases was not clear in
this study, except for 2 patients with hypertrophic
cardiomyopathy.
The authors of the current study are to be com-
mended for adding to a growing body of data showing
the utility of CMR in assessing patients with atrial
ﬁbrillation before ablation. Similar to computed to-
mography, CMR provides anatomic data helpful for
procedure planning. However, CMR has several
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803advantages over computed tomography. This in-
cludes detailed tissue characterization of the
myocardium, which, as shown by this study, provides
additive prognostic information. Within the same
procedure, CMR also provides high-resolution func-
tional assessment of ventricular and atrial function.
In addition, left atrial tissue characterization with
LGE imaging potentially provides direct information
regarding the underlying substrate for atrial ﬁbrilla-
tion and is an area of active research. Finally,
emerging techniques (such as 4-dimensional ﬂow)that provide detailed blood ﬂow patterns within the
left atrium may give further mechanistic insights in
the future. We agree with the authors that when
available, CMR should be considered before atrial
ﬁbrillation ablation.
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